PureTech Health PLC
LSE:PRTC

Watchlist Manager
PureTech Health PLC Logo
PureTech Health PLC
LSE:PRTC
Watchlist
Price: 168.6 GBX -2.09% Market Closed
Market Cap: 403.6m GBX
Have any thoughts about
PureTech Health PLC?
Write Note

PureTech Health PLC
Cash Equivalents

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

PureTech Health PLC
Cash Equivalents Peer Comparison

Comparables:
ABBV
GILD
AMGN
VRTX
REGN

Competitive Cash Equivalents Analysis
Latest Figures & CAGR of Competitors

Company Cash Equivalents CAGR 3Y CAGR 5Y CAGR 10Y
PureTech Health PLC
LSE:PRTC
Cash Equivalents
$191.1m
CAGR 3-Years
-22%
CAGR 5-Years
10%
CAGR 10-Years
N/A
Abbvie Inc
NYSE:ABBV
Cash Equivalents
$7.3B
CAGR 3-Years
-16%
CAGR 5-Years
-7%
CAGR 10-Years
-1%
Gilead Sciences Inc
NASDAQ:GILD
Cash Equivalents
$5B
CAGR 3-Years
5%
CAGR 5-Years
-12%
CAGR 10-Years
-2%
Amgen Inc
NASDAQ:AMGN
Cash Equivalents
$9B
CAGR 3-Years
-9%
CAGR 5-Years
-5%
CAGR 10-Years
9%
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
Cash Equivalents
$6.5B
CAGR 3-Years
1%
CAGR 5-Years
14%
CAGR 10-Years
25%
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
Cash Equivalents
$2B
CAGR 3-Years
-16%
CAGR 5-Years
8%
CAGR 10-Years
12%

See Also

What is PureTech Health PLC's Cash Equivalents?
Cash Equivalents
191.1m USD

Based on the financial report for Dec 31, 2023, PureTech Health PLC's Cash Equivalents amounts to 191.1m USD.

What is PureTech Health PLC's Cash Equivalents growth rate?
Cash Equivalents CAGR 5Y
10%

Over the last year, the Cash Equivalents growth was 28%. The average annual Cash Equivalents growth rates for PureTech Health PLC have been -22% over the past three years , 10% over the past five years .

Back to Top